Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Yokokawa, K.
space
  arrow  Saklayen, M. G.
space
 arrow  PubMed                        
space

REPLY

Nitric Oxide and Hemodialysis-Induced Hypotension

right arrow Koji Yokokawa, MD, PhD; K. Anil Mandal, MD; and Mohammad G. Saklayen, MD

15 February 1996 | Volume 124 Issue 4 | Page 454


IN RESPONSE:

Dr. Perazella has raised an important question about a possible relation between hematocrit and plasma nitric oxide levels that may affect the lowering of blood pressure by heparin.

We compared hematocrit values and plasma ferritin levels in patients who had a hypotensive episode during hemodialysis with those of patients who did not have a hypotensive episode. No significant difference was seen in hematocrit values or plasma ferritin levels (P > 0.2 for both comparisons) between the two groups, as shown by an unpaired t-test. Simple regression analysis showed no significant correlation between plasma nitric oxide levels after hemodialysis and hematocrit values (P > 0.2). Furthermore, no significant correlation was seen between hematocrit values and mean blood pressure after hemodialysis (P > 0.2), suggesting that changes in hematocrit do not contribute to the release or production of nitric oxide between the two groups.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info

Osaka City University Medical School; Osaka 545, Japan
Wright State University; Dayton, OH 45428

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Yokokawa, K.
space
  arrow  Saklayen, M. G.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online